DANIEL B. SOLAND - 22 Jun 2021 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
Director
Signature
/s/ Austin D. Kim, Attorney-in-Fact
Issuer symbol
ACAD
Transactions as of
22 Jun 2021
Net transactions value
$0
Form type
4
Filing time
05 Jun 2023, 21:46:39 UTC
Previous filing
21 Jun 2021
Next filing
12 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACAD Common Stock Options Exercise +3,059 +31% 13,059 22 Jun 2021 Direct F1
transaction ACAD Common Stock Options Exercise +6,391 +49% 19,450 07 Jun 2022 Direct F1
transaction ACAD Common Stock Options Exercise +8,552 +44% 28,002 01 Jun 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACAD Restricted Stock Units Options Exercise $0 -3,059 -100% $0.000000* 0 22 Jun 2021 Common Stock 3,059 Direct F1, F2
transaction ACAD Restricted Stock Units Options Exercise $0 -6,391 -100% $0.000000* 0 07 Jun 2022 Common Stock 6,391 Direct F1, F2
transaction ACAD Restricted Stock Units Options Exercise $0 -8,552 -100% $0.000000* 0 01 Jun 2023 Common Stock 8,552 Direct F1, F2
transaction ACAD Director Stock Options (Right to Buy) Award $0 +11,045 $0.000000 11,045 01 Jun 2023 Common Stock 11,045 $23.90 Direct F3
transaction ACAD Restricted Stock Units Award $0 +6,652 $0.000000 6,652 01 Jun 2023 Common Stock 6,652 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Acadia common stock.
F2 The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date.
F3 The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date.